# Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice; establishment of a public docket; request for comments; correction.
**SUMMARY:**
The Food and Drug Administration is correcting a notice entitled “Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments” that appeared in the *Federal Register* of February 22, 2018. The document was published with the incorrect docket number. This document corrects that error.
**FOR FURTHER INFORMATION CONTACT:**
Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.
**SUPPLEMENTARY INFORMATION:**
In the *Federal Register* of Thursday, February 22, 2018 (83 FR 7727), in FR Doc. 2018-03603, on page 7727, the following correction is made:
1. On page 7727, in the first column, in the header of the document, the docket number is corrected to read “FDA-2018-N-0410.”
Dated: March 5, 2018.
Leslie Kux,
Associate Commissioner for Policy.